Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Neutralization Tests"" wg kryterium: Temat


Tytuł :
SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays.
Autorzy :
Walker GJ; Virology Research Laboratory, Prince of Wales Hospital, Sydney, NSW 2031, Australia.; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, NSW 2052, Australia.
Naing Z; Serology and Virology Division (SaViD), NSW Health Pathology, Prince of Wales Hospital, Sydney, NSW 2031, Australia.
Ospina Stella A; Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
Yeang M; Virology Research Laboratory, Prince of Wales Hospital, Sydney, NSW 2031, Australia.; Serology and Virology Division (SaViD), NSW Health Pathology, Prince of Wales Hospital, Sydney, NSW 2031, Australia.
Caguicla J; Serology and Virology Division (SaViD), NSW Health Pathology, Prince of Wales Hospital, Sydney, NSW 2031, Australia.
Ramachandran V; Serology and Virology Division (SaViD), NSW Health Pathology, Prince of Wales Hospital, Sydney, NSW 2031, Australia.
Isaacs SR; Virology Research Laboratory, Prince of Wales Hospital, Sydney, NSW 2031, Australia.
Agapiou D; Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
Bull RA; Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
Stelzer-Braid S; Virology Research Laboratory, Prince of Wales Hospital, Sydney, NSW 2031, Australia.; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, NSW 2052, Australia.
Daly J; Australian Red Cross Lifeblood, 417 St Kilda Rd, Melbourne, VIC 3004, Australia.
Gosbell IB; Australian Red Cross Lifeblood, 417 St Kilda Rd, Melbourne, VIC 3004, Australia.; School of Medicine, Western Sydney University, Penrith, NSW 2747, Australia.
Hoad VC; Australian Red Cross Lifeblood, 417 St Kilda Rd, Melbourne, VIC 3004, Australia.
Irving DO; Australian Red Cross Lifeblood, 417 St Kilda Rd, Melbourne, VIC 3004, Australia.; Faculty of Health, University of Technology, Sydney, NSW 2007, Australia.
Pink JM; Australian Red Cross Lifeblood, 417 St Kilda Rd, Melbourne, VIC 3004, Australia.
Turville S; Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
Kelleher AD; Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
Rawlinson WD; Virology Research Laboratory, Prince of Wales Hospital, Sydney, NSW 2031, Australia.; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, NSW 2052, Australia.; Serology and Virology Division (SaViD), NSW Health Pathology, Prince of Wales Hospital, Sydney, NSW 2031, Australia.; School of Biotechnology and Biomolecular Sciences, Faculty of Science, University of New South Wales, Sydney, NSW 2052, Australia.
Pokaż więcej
Źródło :
Viruses [Viruses] 2021 Feb 04; Vol. 13 (2). Date of Electronic Publication: 2021 Feb 04.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19 Serological Testing*
Enzyme-Linked Immunosorbent Assay*
Neutralization Tests*
Antibodies, Viral/*blood
COVID-19/*immunology
SARS-CoV-2/*immunology
COVID-19/diagnosis ; Humans ; Immunoglobulin A/blood ; Immunoglobulin G/blood ; ROC Curve ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
High-throughput viral microneutralization method for feline coronavirus using image cytometry.
Autorzy :
Pearson M; Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, 80523, United States.
LaVoy A; Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, 80523, United States.
Chan LL; Department of Advanced Technology R&D, Nexcelom Bioscience LLC, Lawrence, MA, 01843, United States. Electronic address: .
Dean GA; Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, 80523, United States.
Pokaż więcej
Źródło :
Journal of virological methods [J Virol Methods] 2020 Dec; Vol. 286, pp. 113979. Date of Electronic Publication: 2020 Sep 23.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Coronavirus Infections/*veterinary
Coronavirus, Feline/*isolation & purification
High-Throughput Screening Assays/*veterinary
Image Cytometry/*methods
Neutralization Tests/*methods
Animals ; Cat Diseases/diagnosis ; Cat Diseases/virology ; Cats ; Cell Line ; Coronavirus Infections/diagnosis ; Coronavirus Infections/virology ; Feline Infectious Peritonitis/diagnosis ; Feline Infectious Peritonitis/virology ; High-Throughput Screening Assays/methods ; Image Cytometry/veterinary ; Neutralization Tests/veterinary ; Viral Load
Czasopismo naukowe
Tytuł :
A comparison of SARS-CoV-2 antibody assays evaluated in Auckland, New Zealand.
Autorzy :
Fox-Lewis S; Clinical Virology Registrar, Department of Virology-Immunology, LabPLUS, Auckland City Hospital, Auckland.
Whitcombe A; PhD Student, Faculty of Medical and Health Sciences, University of Auckland, Auckland; Maurice Wilkins Centre, University of Auckland, Auckland.
McGregor R; Post-Doctoral Research Fellow, Faculty of Medical and Health Sciences, University of Auckland, Auckland; Maurice Wilkins Centre, University of Auckland, Auckland.
Carlton L; Research Technician, Faculty of Medical and Health Sciences, University of Auckland, Auckland.
Hwang Y; Registered Medical Laboratory Scientist, Department of Virology-Immunology, LabPLUS, Auckland City Hospital, Auckland.
Austin P; Section Leader For Serology, Department of Virology-Immunology, LabPLUS, Auckland City Hospital, Auckland.
Aspin L; Head of the Department of Biochemistry and Immunology, Department of Biochemistry and Immunology, Labtests, Auckland.
Raill B; Section Head for Toxicology and Immunoassay, Department of Biochemistry, Middlemore Hospital, Auckland.
Webb R; Consultant Paediatrician, Paediatric Infectious Diseases, Faculty of Medical and Health Sciences, University of Auckland, Auckland; Starship Children's Hospital, Auckland; KidzFirst Children's Hospital, Middlemore Hospital, Auckland.
Taylor S; Clinical Microbiologist, Department of Microbiology, Middlemore Hospital, Auckland.
Morpeth S; Clinical Microbiologist, Department of Microbiology, Middlemore Hospital, Auckland.
Roberts S; Clinical Microbiologist, Head of Department of Microbiology Maurice Wilkins Centre, University of Auckland, Auckland; Department of Microbiology, LabPLUS, Auckland City Hospital, Auckland.
Moreland NJ; Senior Lecturer, Faculty of Medical and Health Sciences, University of Auckland, Auckland; Maurice Wilkins Centre, University of Auckland, Auckland.
McAuliffe G; Clinical Microbiologist, Head of Department of Virology, Department of Virology-Immunology, LabPLUS, Auckland City Hospital, Auckland; Department of Microbiology, Labtests, Auckland.
Pokaż więcej
Źródło :
The New Zealand medical journal [N Z Med J] 2020 Nov 20; Vol. 133 (1525), pp. 127-131. Date of Electronic Publication: 2020 Nov 20.
Typ publikacji :
Letter
MeSH Terms :
COVID-19*/diagnosis
COVID-19*/epidemiology
COVID-19*/immunology
COVID-19*/virology
COVID-19 Serological Testing*/methods
COVID-19 Serological Testing*/standards
Neutralization Tests*/methods
Neutralization Tests*/standards
SARS-CoV-2*/immunology
SARS-CoV-2*/isolation & purification
Clinical Laboratory Techniques/methods ; Clinical Laboratory Techniques/standards ; Comparative Effectiveness Research ; Humans ; New Zealand/epidemiology ; Predictive Value of Tests ; Reagent Kits, Diagnostic/classification ; Sensitivity and Specificity
Opinia redakcyjna
Tytuł :
Peptide enzyme-linked immunosorbent assay (pELISA) as a possible alternative to the neutralization test for evaluating the immune response to IBV vaccine.
Autorzy :
Wu Q; Key Laboratory of Avian Preventive Medicine, Ministry of Education, Yangzhou University, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China.; Jiangsu Key Lab of Zoonosis, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China.
Lin Z; Key Laboratory of Avian Preventive Medicine, Ministry of Education, Yangzhou University, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China.; Jiangsu Key Lab of Zoonosis, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China.
Wu J; Key Laboratory of Avian Preventive Medicine, Ministry of Education, Yangzhou University, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China.; Jiangsu Key Lab of Zoonosis, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China.
Qian K; Key Laboratory of Avian Preventive Medicine, Ministry of Education, Yangzhou University, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China.; Jiangsu Key Lab of Zoonosis, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China.; The International Joint Laboratory for Cooperation in Agriculture and Agricultural Product Safety, Ministry of Education, Yangzhou University, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China.
Shao H; Key Laboratory of Avian Preventive Medicine, Ministry of Education, Yangzhou University, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China.; Jiangsu Key Lab of Zoonosis, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China.; The International Joint Laboratory for Cooperation in Agriculture and Agricultural Product Safety, Ministry of Education, Yangzhou University, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China.
Ye J; Key Laboratory of Avian Preventive Medicine, Ministry of Education, Yangzhou University, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China. .; Jiangsu Key Lab of Zoonosis, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China. .; The International Joint Laboratory for Cooperation in Agriculture and Agricultural Product Safety, Ministry of Education, Yangzhou University, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China. .; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China. .; Ministry of Education Key Lab for Avian Preventive Medicine, Yangzhou University, No. 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China. .
Qin A; Key Laboratory of Avian Preventive Medicine, Ministry of Education, Yangzhou University, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China. .; Jiangsu Key Lab of Zoonosis, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China. .; The International Joint Laboratory for Cooperation in Agriculture and Agricultural Product Safety, Ministry of Education, Yangzhou University, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China. .; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China. .; Ministry of Education Key Lab for Avian Preventive Medicine, Yangzhou University, No. 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China. .
Pokaż więcej
Źródło :
BMC veterinary research [BMC Vet Res] 2021 Jan 25; Vol. 17 (1), pp. 51. Date of Electronic Publication: 2021 Jan 25.
Typ publikacji :
Journal Article
MeSH Terms :
Enzyme-Linked Immunosorbent Assay*/methods
Neutralization Tests*/methods
Coronavirus Infections/*prevention & control
Infectious bronchitis virus/*immunology
Poultry Diseases/*prevention & control
Animals ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; Chickens/immunology ; Chickens/virology ; Coronavirus Infections/immunology ; Poultry Diseases/immunology ; Poultry Diseases/virology ; Reproducibility of Results ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
Evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test for Detection of Antibody in Human, Canine, Cat, and Hamster Sera.
Autorzy :
Perera RAPM; School of Public Health, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China.
Ko R; School of Public Health, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China.
Tsang OTY; Infectious Diseases Centre, Princess Margaret Hospital, Hospital Authority of Hong Kong, Kwai Chung, Hong Kong Special Administrative Region, China.
Hui DSC; Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
Kwan MYM; Department of Paediatric and Adolescent Medicine, Princess Margaret Hospital, Hospital Authority of Hong Kong, Kwai Chung, Hong Kong Special Administrative Region, China.
Brackman CJ; Agriculture, Fisheries and Conservation Department, Government of the Hong Kong Special Administrative Region, Hong Kong Special Administrative Region, China.
To EMW; Agriculture, Fisheries and Conservation Department, Government of the Hong Kong Special Administrative Region, Hong Kong Special Administrative Region, China.
Yen HL; School of Public Health, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China.
Leung K; School of Public Health, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China.; Laboratory of Data Discovery for Health (D4H), New Territories, Hong Kong Special Administrative Region, China.
Cheng SMS; School of Public Health, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China.
Chan KH; School of Public Health, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China.
Chan KCK; School of Public Health, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China.
Li KC; School of Public Health, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China.
Saif L; Food Animal Health Research Program, OARDC/The Ohio State University, Wooster, Ohio, USA.
Barrs VR; Jockey Club College of Veterinary Medicine & Life Sciences, City University of Hong Kong, Kowloon Tong, Hong Kong Special Administrative Region, China.
Wu JT; School of Public Health, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China.; Laboratory of Data Discovery for Health (D4H), New Territories, Hong Kong Special Administrative Region, China.
Sit THC; Agriculture, Fisheries and Conservation Department, Government of the Hong Kong Special Administrative Region, Hong Kong Special Administrative Region, China.
Poon LLM; School of Public Health, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China.; HKU-Pasteur Research Pole, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China.
Peiris M; School of Public Health, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China .; HKU-Pasteur Research Pole, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China.
Pokaż więcej
Źródło :
Journal of clinical microbiology [J Clin Microbiol] 2021 Jan 21; Vol. 59 (2). Date of Electronic Publication: 2021 Jan 21 (Print Publication: 2021).
Typ publikacji :
Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19/*diagnosis
COVID-19 Serological Testing/*methods
Neutralization Tests/*methods
SARS-CoV-2/*isolation & purification
Animals ; Antibodies, Neutralizing/blood ; Antibodies, Viral/blood ; COVID-19/blood ; COVID-19/pathology ; Cats ; Cricetinae ; Cross Reactions ; Dogs ; Female ; Humans ; Immune Sera/immunology ; Male ; Neutralization Tests/standards ; SARS-CoV-2/immunology ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
Seroprevalence of Toscana Virus and Sandfly Fever Sicilian Virus in European Bat Colonies Measured Using a Neutralization Test.
Autorzy :
Ayhan N; Unité des Virus Emergents, Aix Marseille University, IRD 190, INSERM U1207, 13005 Marseille, France.; UR7310, Laboratoire de Virologie, Université de Corse-Inserm, 20250 Corte, France.
López-Roig M; Department of Evolutionary Biology, Ecology and Environmental Sciences, Faculty of Biology, University of Barcelona, 08028 Barcelona, Spain.; Biodiversity Research Institute, University of Barcelona, 08028 Barcelona, Spain.
Monastiri A; Department of Evolutionary Biology, Ecology and Environmental Sciences, Faculty of Biology, University of Barcelona, 08028 Barcelona, Spain.
Charrel RN; Unité des Virus Emergents, Aix Marseille University, IRD 190, INSERM U1207, 13005 Marseille, France.
Serra-Cobo J; Department of Evolutionary Biology, Ecology and Environmental Sciences, Faculty of Biology, University of Barcelona, 08028 Barcelona, Spain.; Biodiversity Research Institute, University of Barcelona, 08028 Barcelona, Spain.
Pokaż więcej
Źródło :
Viruses [Viruses] 2021 Jan 11; Vol. 13 (1). Date of Electronic Publication: 2021 Jan 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Neutralization Tests*/methods
Antibodies, Neutralizing/*blood
Antibodies, Viral/*blood
Chiroptera/*immunology
Chiroptera/*virology
Phlebotomus Fever/*epidemiology
Phlebotomus Fever/*transmission
Sandfly fever Naples virus/*immunology
Animals ; Geography ; Phlebotomus Fever/immunology ; Sandfly fever Naples virus/isolation & purification ; Seroepidemiologic Studies ; Spain/epidemiology
Czasopismo naukowe
Tytuł :
Neutralizing Antibody Responses in COVID-19 Convalescent Sera.
Autorzy :
Lee WT; Wadsworth Center, New York State Department of Health, Albany, New York, USA.; Department of Biomedical Sciences, School of Public Health, State University of New York at Albany, Albany, New York, USA.
Girardin RC; Wadsworth Center, New York State Department of Health, Albany, New York, USA.
Dupuis AP; Wadsworth Center, New York State Department of Health, Albany, New York, USA.
Kulas KE; Wadsworth Center, New York State Department of Health, Albany, New York, USA.
Payne AF; Wadsworth Center, New York State Department of Health, Albany, New York, USA.
Wong SJ; Wadsworth Center, New York State Department of Health, Albany, New York, USA.
Arinsburg S; Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Nguyen FT; Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Mendu DR; Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Firpo-Betancourt A; Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Jhang J; Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Wajnberg A; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Cordon-Cardo C; Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Amler S; Westchester County Department of Health, White Plains, New York, USA.
Montecalvo M; Westchester County Department of Health, White Plains, New York, USA.
Hutton B; New York State Department of Health, Albany, New York, USA.
Taylor J; Wadsworth Center, New York State Department of Health, Albany, New York, USA.
McDonough KA; Wadsworth Center, New York State Department of Health, Albany, New York, USA.; Department of Biomedical Sciences, School of Public Health, State University of New York at Albany, Albany, New York, USA.
Pokaż więcej
Źródło :
The Journal of infectious diseases [J Infect Dis] 2021 Jan 04; Vol. 223 (1), pp. 47-55.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Neutralization Tests*
Antibodies, Neutralizing/*blood
Antibodies, Viral/*blood
COVID-19/*therapy
Enzyme-Linked Immunosorbent Assay ; Humans ; Immunization, Passive
SCR Protocol :
COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
Viral Infectivity Quantification and Neutralization Assays Using Laser Force Cytology.
Autorzy :
Hebert CG; LumaCyte, LLC, Charlottesville, VA, USA. .
Rodrigues KL; LumaCyte, LLC, Charlottesville, VA, USA.
DiNardo N; Thermo Fisher Scientific Inc., Grand Island, NY, USA.
Hachmann AB; Thermo Fisher Scientific Inc., Grand Island, NY, USA.
Pokaż więcej
Źródło :
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2021; Vol. 2183, pp. 575-585.
Typ publikacji :
Journal Article
MeSH Terms :
Neutralization Tests*
Viral Load*
Viral Plaque Assay*
Antibodies, Neutralizing/*immunology
Antibodies, Viral/*immunology
Virus Diseases/*immunology
Virus Diseases/*virology
Animals ; Cell Adhesion ; Chlorocebus aethiops ; HEK293 Cells ; Humans ; Sf9 Cells ; Vaccines/immunology ; Vero Cells ; Virus Diseases/prevention & control
Czasopismo naukowe
Tytuł :
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2.
Autorzy :
Nie J; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Li Q; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.; Graduate School of Peking Union Medical College, Beijing, People's Republic of China.
Wu J; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.; Wuhan Institute of Biological Products, Wuhan, People's Republic of China.
Zhao C; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Hao H; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Liu H; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Zhang L; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Nie L; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Qin H; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Wang M; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Lu Q; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Li X; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Sun Q; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Liu J; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Fan C; Division of Animal Model Research, Institute for Laboratory Animal Resources, National Institutes for Food and Drug Control, Beijing, People's Republic of China.
Huang W; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Xu M; Institute for Biological Product Control, National Institutes for Food and Drug Control, Beijing, People's Republic of China.
Wang Y; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.; Graduate School of Peking Union Medical College, Beijing, People's Republic of China.
Pokaż więcej
Źródło :
Emerging microbes & infections [Emerg Microbes Infect] 2020 Dec; Vol. 9 (1), pp. 680-686.
Typ publikacji :
Journal Article; Validation Study
MeSH Terms :
Neutralization Tests*
Antibodies, Neutralizing/*immunology
Antibodies, Viral/*immunology
Betacoronavirus/*immunology
Coronavirus Infections/*immunology
Immune Sera/*immunology
Pneumonia, Viral/*immunology
Spike Glycoprotein, Coronavirus/*immunology
Animals ; COVID-19 ; Cell Line ; Coronavirus Infections/therapy ; Humans ; Immunization, Passive ; Limit of Detection ; Membrane Glycoproteins/immunology ; Mice ; Plasmids ; Reproducibility of Results ; SARS-CoV-2 ; Sensitivity and Specificity ; Spike Glycoprotein, Coronavirus/genetics ; Vesicular stomatitis Indiana virus/genetics ; Viral Envelope Proteins/immunology ; Virus Internalization
SCR Protocol :
COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
Development of a receptor-based inhibitory penta-unit-conjugated peptide to enhance anthrax toxin neutralization.
Autorzy :
Lee SC; Department of Chemistry, Georgia State University, Atlanta, GA 30303, USA. Electronic address: .
Yoon MY; Department of Chemistry and Research Institute for Natural Sciences, Hanyang University, Seoul 04763, Republic of Korea. Electronic address: .
Pokaż więcej
Źródło :
International journal of biological macromolecules [Int J Biol Macromol] 2020 Nov 15; Vol. 163, pp. 327-335. Date of Electronic Publication: 2020 Jul 01.
Typ publikacji :
Journal Article
MeSH Terms :
Neutralization Tests*
Antigens, Bacterial/*chemistry
Bacterial Toxins/*chemistry
Oligosaccharides/*chemistry
Oligosaccharides/*pharmacology
Peptides/*chemistry
Peptides/*pharmacology
Receptors, Peptide/*antagonists & inhibitors
Receptors, Peptide/*chemistry
Animals ; Cell Surface Display Techniques ; Humans ; Macrophages ; Mice ; Peptide Library ; Protein Binding ; RAW 264.7 Cells ; Structure-Activity Relationship
Czasopismo naukowe
Tytuł :
Clinical performances of an ELISA for SARS-CoV-2 antibody assay and correlation with neutralization activity.
Autorzy :
Padoan A; Department of Laboratory Medicine, University-Hospital of Padova, Italy; Department of Medicine-DIMED, University of Padova, Italy.
Zuin S; Department of Laboratory Medicine, University-Hospital of Padova, Italy; Department of Medicine-DIMED, University of Padova, Italy.
Cosma C; Department of Laboratory Medicine, University-Hospital of Padova, Italy; Department of Medicine-DIMED, University of Padova, Italy.
Basso D; Department of Laboratory Medicine, University-Hospital of Padova, Italy; Department of Medicine-DIMED, University of Padova, Italy.
Plebani M; Department of Laboratory Medicine, University-Hospital of Padova, Italy; Department of Medicine-DIMED, University of Padova, Italy. Electronic address: .
Bonfante F; Laboratory of Experimental Animal Models, Division of Comparative Biomedical Sciences, Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Italy.
Pokaż więcej
Źródło :
Clinica chimica acta; international journal of clinical chemistry [Clin Chim Acta] 2020 Nov; Vol. 510, pp. 654-655. Date of Electronic Publication: 2020 Aug 18.
Typ publikacji :
Letter
MeSH Terms :
Betacoronavirus*/isolation & purification
Antibodies, Neutralizing/*blood
Antibodies, Viral/*blood
Coronavirus Infections/*blood
Neutralization Tests/*standards
Pneumonia, Viral/*blood
COVID-19 ; Coronavirus Infections/diagnosis ; Enzyme-Linked Immunosorbent Assay/methods ; Enzyme-Linked Immunosorbent Assay/standards ; Humans ; Neutralization Tests/methods ; Pandemics ; Pneumonia, Viral/diagnosis ; SARS-CoV-2 ; Time Factors
Opinia redakcyjna
Tytuł :
Plaque Reduction Neutralization Test (PRNT) in the Congenital Zika Syndrome: Positivity and Associations with Laboratory, Clinical, and Imaging Characteristics.
Autorzy :
Ribeiro MRC; Department of Medicine III, Federal University of Maranhão, Praça Gonçalves Dias, 21, Centro, São Luís CEP 65020-240, MA, Brazil.
Khouri R; Laboratory of Vector-Borne Infectious Diseases, Gonçalo Moniz Institute, Fiocruz-Bahia, Rua Waldemar Falcão, 121, Candeal, Salvador CEP 40296-710, BA, Brazil.; Department of Pathology and Legal Medicine, Faculty of Medicine, Federal University of Bahia, Praça XV de Novembro, s/n-Largo do Terreiro de Jesus, Salvador CEP 40026-010, BA, Brazil.
Sousa PS; Reference Center on Neurodevelopment, Assistance and Rehabilitation of Children/NINAR- Health Secretariat of the State of Maranhão, Av. dos Holandeses, s/n, São Luís CEP 65077-357, MA, Brazil.
Branco MRFC; Department of Pathology, Federal University of Maranhão, Praça Madre Deus, 2, Madre Deus, São Luís CEP 65025-560, MA, Brazil.
Batista RFL; Department of Public Health, Federal University of Maranhão, Rua Barão de Itapary, 155, Centro, São Luís CEP 65020-070, MA, Brazil.
Costa EPF; Department of Medicine I, Federal University of Maranhão, Praça Gonçalves Dias, 21, Centro, São Luís CEP 65020-240, MA, Brazil.
Alves MTSSB; Department of Public Health, Federal University of Maranhão, Rua Barão de Itapary, 155, Centro, São Luís CEP 65020-070, MA, Brazil.
Amaral GA; Sarah Network of Neurorehabilitation Hospitals, Av. Luis Rocha, s/n, Monte Castelo, São Luís CP 65035-270, MA, Brazil.
Borges MCR; Diagnostic Imaging Department, Federal University of São Paulo, Rua Napoleão de Barros, 800, São Paulo CEP 04024-002, SP, Brazil.
Takahasi EHM; Sarah Network of Neurorehabilitation Hospitals, Av. Luis Rocha, s/n, Monte Castelo, São Luís CP 65035-270, MA, Brazil.
Gomes LN; Laboratory of Human Immunology, Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 1730, Cidade Universitária, São Paulo CEP 05508-900, SP, Brazil.
Mendes AKT; Department of Public Health, Federal University of Maranhão, Rua Barão de Itapary, 155, Centro, São Luís CEP 65020-070, MA, Brazil.
Cavalcante TB; Department of Public Health, Federal University of Maranhão, Rua Barão de Itapary, 155, Centro, São Luís CEP 65020-070, MA, Brazil.
Costa LC; Department of Public Health, Federal University of Maranhão, Rua Barão de Itapary, 155, Centro, São Luís CEP 65020-070, MA, Brazil.
Félix AC; Laboratory of Virology, Institute of Tropical Medicine, University of São Paulo, Av. Dr. Enéas Carvalho de Aguiar, 470, São Paulo CEP 05403-000, SP, Brazil.
Souza NCS; Laboratory of Virology, Institute of Tropical Medicine, University of São Paulo, Av. Dr. Enéas Carvalho de Aguiar, 470, São Paulo CEP 05403-000, SP, Brazil.
Silva AAM; Department of Public Health, Federal University of Maranhão, Rua Barão de Itapary, 155, Centro, São Luís CEP 65020-070, MA, Brazil.
Pokaż więcej
Źródło :
Viruses [Viruses] 2020 Oct 31; Vol. 12 (11). Date of Electronic Publication: 2020 Oct 31.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Neutralization Tests*
Viral Plaque Assay*
Zika Virus Infection/*congenital
Zika Virus Infection/*diagnosis
Brazil ; Child, Preschool ; Clinical Laboratory Techniques ; Cohort Studies ; Cross Reactions ; Female ; Humans ; Infant ; Pregnancy ; Serologic Tests ; Tomography
Czasopismo naukowe
Tytuł :
Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients.
Autorzy :
Deshpande GR; Diagnostic Virology Group, Pimpri Chinchwad Municipal Corporation, Pune, Maharashtra, India.
Sapkal GN; Diagnostic Virology Group, Pimpri Chinchwad Municipal Corporation, Pune, Maharashtra, India.
Tilekar BN; Diagnostic Virology Group, Pimpri Chinchwad Municipal Corporation, Pune, Maharashtra, India.
Yadav PD; Maximum Containment Facility, ICMR-National Institute of Virology, Pune, Maharashtra, India.
Gurav Y; Epidemiology Group, ICMR-National Institute of Virology, Pune, Maharashtra, India.
Gaikwad S; Diagnostic Virology Group, Pimpri Chinchwad Municipal Corporation, Pune, Maharashtra, India.
Kaushal H; Influenza Group, ICMR-National Institute of Virology, Pune, Maharashtra, India.
Deshpande KS; Diagnostic Virology Group, Pimpri Chinchwad Municipal Corporation, Pune, Maharashtra, India.
Kaduskar O; Diagnostic Virology Group, Pimpri Chinchwad Municipal Corporation, Pune, Maharashtra, India.
Sarkale P; Maximum Containment Facility, ICMR-National Institute of Virology, Pune, Maharashtra, India.
Baradkar S; Maximum Containment Facility, ICMR-National Institute of Virology, Pune, Maharashtra, India.
Suryawanshi A; Maximum Containment Facility, ICMR-National Institute of Virology, Pune, Maharashtra, India.
Lakra R; Maximum Containment Facility, ICMR-National Institute of Virology, Pune, Maharashtra, India.
Sugunan AP; ICMR-National Institute of Virology, Kerala Unit, Alappuzha, Kerala, India.
Balakrishnan A; ICMR-National Institute of Virology, Kerala Unit, Alappuzha, Kerala, India.
Abraham P; Diagnostic Virology Group, Pimpri Chinchwad Municipal Corporation, Pune, Maharashtra, India.
Salve P; Medical Department, Pimpri Chinchwad Municipal Corporation, Pune, Maharashtra, India.
Pokaż więcej
Źródło :
The Indian journal of medical research [Indian J Med Res] 2020 Jul & Aug; Vol. 152 (1 & 2), pp. 82-87.
Typ publikacji :
Journal Article
MeSH Terms :
Neutralization Tests*
Pandemics*
Antibodies, Neutralizing/*isolation & purification
Coronavirus Infections/*blood
Pneumonia, Viral/*blood
Adolescent ; Adult ; Animals ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/blood ; Betacoronavirus/immunology ; Betacoronavirus/pathogenicity ; COVID-19 ; Child ; Chlorocebus aethiops/immunology ; Coronavirus Infections/epidemiology ; Coronavirus Infections/immunology ; Coronavirus Infections/virology ; Female ; Humans ; Immunoglobulin G/blood ; Male ; Middle Aged ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/immunology ; Pneumonia, Viral/virology ; SARS-CoV-2 ; Vero Cells/immunology ; Young Adult
Czasopismo naukowe
Tytuł :
An in vitro methodology for discovering broadly-neutralizing monoclonal antibodies.
Autorzy :
Ahmadi S; Department of Biotechnology and Biosafety, Graduate School of Natural and Applied Sciences, Eskisehir Osmangazi University, Eskisehir, Turkey.; Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark.
Pucca MB; Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark.; Medical School, Federal University of Roraima, Boa Vista, Roraima, Brazil.
Jürgensen JA; Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark.
Janke R; Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark.
Ledsgaard L; Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark.
Schoof EM; Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark.
Sørensen CV; Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark.
Çalışkan F; Department of Biotechnology and Biosafety, Graduate School of Natural and Applied Sciences, Eskisehir Osmangazi University, Eskisehir, Turkey.; Department of Biology, Faculty of Science and Letters, Eskisehir Osmangazi University, Eskisehir, Turkey.
Laustsen AH; Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2020 Jul 01; Vol. 10 (1), pp. 10765. Date of Electronic Publication: 2020 Jul 01.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Neutralization Tests*
Antibodies, Monoclonal/*chemistry
Antibodies, Neutralizing/*chemistry
Antivenins/*chemistry
Animals ; Antigens/chemistry ; Biotechnology ; Cross Reactions/immunology ; Drug Design ; Enzyme-Linked Immunosorbent Assay ; Humans ; Immunoglobulin Fab Fragments/immunology ; In Vitro Techniques ; Inhibitory Concentration 50 ; Keratinocytes/immunology ; Mass Spectrometry ; Peptide Library ; Proteomics ; Recombinant Proteins/chemistry ; Snakes ; Venoms
Czasopismo naukowe
Tytuł :
Preparation and qualification of internal rabies reference standards for use in the rabies rapid fluorescent focus inhibition test.
Autorzy :
Timiryasova TM; Sanofi Pasteur, 1 Discovery Drive, Swiftwater, PA, 18370, USA. .
Hodge SA; Sanofi Pasteur, 1 Discovery Drive, Swiftwater, PA, 18370, USA.
Zheng L; Sanofi Pasteur, 1 Discovery Drive, Swiftwater, PA, 18370, USA.
Singer A; Sanofi Pasteur, 1 Discovery Drive, Swiftwater, PA, 18370, USA.
Vincent D; Sanofi Pasteur, 1 Discovery Drive, Swiftwater, PA, 18370, USA.
Rahman M; Sanofi Pasteur, 1 Discovery Drive, Swiftwater, PA, 18370, USA.
Petit C; Sanofi Pasteur, 1 Discovery Drive, Swiftwater, PA, 18370, USA.
Brown M; Sanofi Pasteur, 1 Discovery Drive, Swiftwater, PA, 18370, USA.
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2020 Jun 18; Vol. 10 (1), pp. 9893. Date of Electronic Publication: 2020 Jun 18.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Neutralization Tests/*standards
Rabies/*diagnosis
Antibodies, Viral/blood ; Antibodies, Viral/immunology ; Antigen-Antibody Reactions ; Antigens, Viral/immunology ; Humans ; Immunoglobulin G/blood ; Immunoglobulin G/immunology ; Limit of Detection ; Neutralization Tests/methods ; Rabies/virology ; Rabies Vaccines/immunology ; Rabies virus/immunology ; Reference Standards ; Reproducibility of Results ; Sensitivity and Specificity ; World Health Organization
Czasopismo naukowe
Tytuł :
Microneutralization assay titer correlates analysis in two phase 3 trials of the CYD-TDV tetravalent dengue vaccine in Asia and Latin America.
Autorzy :
Carpp LN; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Fong Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America.
Bonaparte M; Global Clinical Immunology, Sanofi Pasteur, Swiftwater, Pennsylvania, United States of America.
Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Juraska M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America.
Price B; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America.
Zhuang Y; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America.
Shao J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Zheng L; Global Clinical Immunology, Sanofi Pasteur, Swiftwater, Pennsylvania, United States of America.
Chambonneau L; Clinical Sciences, Sanofi Pasteur, Marcy-L'Etoile, France.
Small R; Sanofi Pasteur, Orlando, Florida, United States of America.
Sridhar S; Clinical Sciences, Sanofi Pasteur, Marcy-L'Etoile, France.
DiazGranados CA; Clinical Sciences, Sanofi Pasteur, Swiftwater, Pennsylvania, United States of America.
Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Jun 15; Vol. 15 (6), pp. e0234236. Date of Electronic Publication: 2020 Jun 15 (Print Publication: 2020).
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Neutralization Tests*
Dengue Vaccines/*immunology
Adolescent ; Asia ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Latin America ; Male
Czasopismo naukowe
Tytuł :
Accuracy and efficacy of pre-dengue vaccination screening for previous dengue infection with five commercially available immunoassays: a retrospective analysis of phase 3 efficacy trials.
Autorzy :
DiazGranados CA; Global Clinical Science, Sanofi Pasteur, Marcy l'Etoile, France. Electronic address: .
Bonaparte M; Global Clinical Immunology, Sanofi Pasteur, Swiftwater, PA, USA.
Wang H; Sanofi, Beijing, China.
Zhu M; Global Clinical Immunology, Sanofi Pasteur, Swiftwater, PA, USA.
Lustig Y; Central Virology Laboratory, Public Health Services, Israel Ministry of Health, Chaim Sheba Medical Center, Ramat Gan, Israel.
Schwartz E; Institute of Tropical Medicine, Chaim Sheba Medical Center & Sackler Faculty of Medicine, Tel-Aviv University, Israel.
Forrat R; Research and Development Department, Sanofi Pasteur, Lyon, France.
Dayan GH; Research and Development Department, Sanofi Pasteur, Lyon, France.
Hodge S; Global Clinical Immunology, Sanofi Pasteur, Swiftwater, PA, USA.
Ataman-Önal Y; Translational Sciences and Biomarkers, Sanofi Pasteur, Marcy l'Etoile, France.
Savarino SJ; Translational Sciences and Biomarkers, Sanofi Pasteur, Swiftwater, PA, USA.
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Apr; Vol. 21 (4), pp. 529-536. Date of Electronic Publication: 2020 Nov 16.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Dengue/*diagnosis
Dengue Vaccines/*adverse effects
Dengue Virus/*immunology
Immunoassay/*instrumentation
Mass Screening/*instrumentation
Adolescent ; Antibodies, Viral/immunology ; Antibodies, Viral/isolation & purification ; Child ; Child, Preschool ; Clinical Trials, Phase III as Topic ; Dengue/immunology ; Dengue/prevention & control ; Dengue/virology ; Dengue Vaccines/administration & dosage ; Female ; Humans ; Immunoassay/statistics & numerical data ; Male ; Mass Screening/statistics & numerical data ; Neutralization Tests/instrumentation ; Neutralization Tests/statistics & numerical data ; Patient Selection ; Reagent Kits, Diagnostic/statistics & numerical data ; Reproducibility of Results ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Correlation of SARS-CoV-2 Neutralizing Antibodies to an Automated Chemiluminescent Serological Immunoassay.
Autorzy :
Grenache DG; TriCore Reference Laboratories, Albuquerque, NM.; Department of Pathology, University of New Mexico, Albuquerque, NM.
Ye C; Department of Internal Medicine, University of New Mexico, Center for Global Health, Albuquerque, NM.
Bradfute SB; Department of Internal Medicine, University of New Mexico, Center for Global Health, Albuquerque, NM.
Pokaż więcej
Źródło :
The journal of applied laboratory medicine [J Appl Lab Med] 2021 Mar 01; Vol. 6 (2), pp. 491-495.
Typ publikacji :
Evaluation Study; Journal Article
MeSH Terms :
Antibodies, Neutralizing/*isolation & purification
Antibodies, Viral/*isolation & purification
COVID-19/*diagnosis
COVID-19 Serological Testing/*standards
SARS-CoV-2/*isolation & purification
Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; COVID-19/blood ; COVID-19/immunology ; COVID-19/virology ; COVID-19 Serological Testing/instrumentation ; COVID-19 Serological Testing/methods ; COVID-19 Serological Testing/statistics & numerical data ; Humans ; Immunoglobulin G/immunology ; Immunoglobulin G/isolation & purification ; Luminescent Measurements/instrumentation ; Luminescent Measurements/standards ; Luminescent Measurements/statistics & numerical data ; Neutralization Tests/standards ; Neutralization Tests/statistics & numerical data ; Reagent Kits, Diagnostic/standards ; SARS-CoV-2/immunology ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with mortality in COVID-19 patients.
Autorzy :
Yang HS; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA; NewYork-Presbyterian Hospital/Weill Cornell Medical Campus, New York, NY, USA.
Racine-Brzostek SE; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA; NewYork-Presbyterian Hospital/Weill Cornell Medical Campus, New York, NY, USA.
Karbaschi M; ET HealthCare, Palo Alto, CA, USA.
Yee J; NewYork-Presbyterian Hospital/Weill Cornell Medical Campus, New York, NY, USA.
Dillard A; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA; NewYork-Presbyterian Hospital/Weill Cornell Medical Campus, New York, NY, USA.
Steel PAD; NewYork-Presbyterian Hospital/Weill Cornell Medical Campus, New York, NY, USA; Department of Emergency Medicine, Weill Cornell Medical Center, New York, NY, USA.
Lee WT; Diagnostic Immunology Laboratory, Wadsworth Center, New York State Department of Health, Albany, NY, USA.
McDonough KA; Diagnostic Immunology Laboratory, Wadsworth Center, New York State Department of Health, Albany, NY, USA.
Qiu Y; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
Ketas TJ; Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA.
Francomano E; Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA.
Klasse PJ; Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA.
Hatem L; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA; NewYork-Presbyterian Hospital/Weill Cornell Medical Campus, New York, NY, USA.
Westblade L; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Wu H; ET HealthCare, Palo Alto, CA, USA.
Chen H; ET HealthCare, Palo Alto, CA, USA.
Zuk R; ET HealthCare, Palo Alto, CA, USA.
Tan H; ET HealthCare, Palo Alto, CA, USA.
Girardin RC; Diagnostic Immunology Laboratory, Wadsworth Center, New York State Department of Health, Albany, NY, USA.
Dupuis AP 2nd; Diagnostic Immunology Laboratory, Wadsworth Center, New York State Department of Health, Albany, NY, USA.
Payne AF; Diagnostic Immunology Laboratory, Wadsworth Center, New York State Department of Health, Albany, NY, USA.
Moore JP; Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA.
Cushing MM; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA; NewYork-Presbyterian Hospital/Weill Cornell Medical Campus, New York, NY, USA.
Chadburn A; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA; NewYork-Presbyterian Hospital/Weill Cornell Medical Campus, New York, NY, USA.
Zhao Z; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA; NewYork-Presbyterian Hospital/Weill Cornell Medical Campus, New York, NY, USA. Electronic address: .
Pokaż więcej
Źródło :
Biosensors & bioelectronics [Biosens Bioelectron] 2021 Apr 15; Vol. 178, pp. 113008. Date of Electronic Publication: 2021 Jan 20.
Typ publikacji :
Journal Article; Validation Study
MeSH Terms :
Antibodies, Viral/*blood
Biosensing Techniques/*instrumentation
COVID-19/*immunology
COVID-19/*mortality
COVID-19 Serological Testing/*instrumentation
SARS-CoV-2/*immunology
Adult ; Aged ; Aged, 80 and over ; Antibodies, Neutralizing/blood ; Biosensing Techniques/statistics & numerical data ; COVID-19/virology ; COVID-19 Nucleic Acid Testing/statistics & numerical data ; COVID-19 Serological Testing/statistics & numerical data ; Cohort Studies ; Equipment Design ; Female ; Humans ; Male ; Middle Aged ; Neutralization Tests/statistics & numerical data ; New York City/epidemiology ; Pandemics ; Proportional Hazards Models ; Retrospective Studies ; Risk Factors ; SARS-CoV-2/genetics ; SARS-CoV-2/isolation & purification ; Sensitivity and Specificity ; Young Adult
Czasopismo naukowe
Tytuł :
Antibody response to SARS-CoV-2 in infected patients with different clinical outcome.
Autorzy :
Anichini G; Virology Unit, Department of Medical Biotechnologies, University of Siena, Siena, Tuscany, Italy.
Gandolfo C; Virology Unit, Department of Medical Biotechnologies, University of Siena, Siena, Tuscany, Italy.; Microbiology and Virology Unit, Santa Maria alle Scotte University Hospital, Siena, Tuscany, Italy.
Terrosi C; Virology Unit, Department of Medical Biotechnologies, University of Siena, Siena, Tuscany, Italy.
Fabrizi S; Preventive Medicine and Health Surveillance Unit, Santa Maria alle Scotte University Hospital, Siena, Tuscany, Italy.
Miceli GB; Preventive Medicine and Health Surveillance Unit, Santa Maria alle Scotte University Hospital, Siena, Tuscany, Italy.
Gori Savellini G; Virology Unit, Department of Medical Biotechnologies, University of Siena, Siena, Tuscany, Italy.
Prathyumnan S; Virology Unit, Department of Medical Biotechnologies, University of Siena, Siena, Tuscany, Italy.
Franchi F; Anesthesia and Intensive Care Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Tuscany, Italy.
Cusi MG; Virology Unit, Department of Medical Biotechnologies, University of Siena, Siena, Tuscany, Italy.; Microbiology and Virology Unit, Santa Maria alle Scotte University Hospital, Siena, Tuscany, Italy.
Pokaż więcej
Źródło :
Journal of medical virology [J Med Virol] 2021 Apr; Vol. 93 (4), pp. 2548-2552. Date of Electronic Publication: 2021 Jan 26.
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies, Viral/*biosynthesis
Antibodies, Viral/*blood
COVID-19/*virology
SARS-CoV-2/*immunology
Adult ; Aged ; Animals ; Antibodies, Neutralizing/blood ; Antibody Formation ; COVID-19/immunology ; Chlorocebus aethiops ; Humans ; Immunity, Humoral ; Immunoglobulin G/blood ; Immunoglobulin G/isolation & purification ; Middle Aged ; Neutralization Tests ; Vero Cells
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies